
Kirstine Nielsen of Aarhus University (Denmark) discusses how targeted metabolomics ratios helped build a robust bloodstain time-since-deposition tool.
Learn how biomarkers, Organ on a Chip Models models and PBPK tools improve toxicity and DDI prediction, cut false positives, and support clearer, ICH M12-aligned decision-making.







